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Background-—Patients with normalized mean pulmonary artery pressure (mPAP) after pulmonary endarterectomy (PEA) for chronic
thromboembolic pulmonary hypertension (CTEPH) do not always regain normal exercise capacity. We evaluated right ventricular
function, its interaction with both pulsatile and resistive afterload, and the effect of sildenafil during exercise in these patients.
Methods and Results-—Fourteen healthy controls, 15 CTEPH patients, and 7 patients with normalized resting mPAP (≤25 mm Hg)
post-PEA underwent cardiopulmonary exercise testing, followed by cardiac magnetic resonance imaging with simultaneous
invasive mPAP measurement during incremental supine cycling exercise. Peak oxygen consumption and peak heart rate were
significantly reduced in post-PEA and CTEPH patients compared to controls. The mPAP–cardiac output slope was steeper in post-
PEA patients than in controls and similar to CTEPH. Relative to controls, resting right ventricular ejection fraction was reduced in
CTEPH, but not in post-PEA patients. In contrast, peak exercise right ventricular ejection fraction was reduced both in post-PEA and
CTEPH patients. Exercise led to reduction of pulmonary arterial compliance in all groups. Nevertheless, resting pulmonary arterial
compliance values in CTEPH and post-PEA patients were even lower than those in controls at peak exercise. In post-PEA patients,
sildenafil did not affect resting hemodynamics nor right ventricular function, but decreased the mPAP/cardiac output slope and
increased peak exercise right ventricular ejection fraction.
Conclusions-—Exercise intolerance in post-PEA patients is explained by abnormal pulmonary vascular reserve and chronotropic
incompetence. The mPAP/cardiac output slope and pulmonary arterial compliance are sensitive measures demonstrating
abnormal resistive and pulsatile pulmonary vascular function in post-PEA patients. These abnormalities are partially attenuated
with sildenafil. ( J Am Heart Assoc. 2015;4:e001602 doi: 10.1161/JAHA.114.001602)
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C hronic thromboembolic pulmonary hypertension (CTEPH)is a serious complication of pulmonary embolism,
occurring in 0.1% to 4% of patients surviving an episode of
acute pulmonary embolism.1,2 Currently, pulmonary endarter-
ectomy (PEA) is the only potentially curative treatment option
resulting in improved functional status, hemodynamics, and
overall survival.3,4 Despite normalization of resting mean
pulmonary artery pressures (mPAP) and pulmonary vascular
resistance (PVR) after PEA,5,6 abnormal increases in right
ventricular (RV) afterload may be apparent during exercise
and may explain the reduced exercise capacity that persists in
many patients.7
Although RV afterload is often described as PVR, a more
complete description is provided by incorporating measures
of both resistive and pulsatile load. Pulmonary arterial
compliance (CPA) represents the distensibility of the pulmo-
nary circulation, whereas PVR is the ratio of mean pressure to
mean flow. It has been suggested that a reduction in CPA
during exercise is the strongest predictor of exercise limita-
tion in post-PEA patients and indicative of an abnormal
pulmonary vascular response to exercise.7 However, the
consequence of an increase in RV afterload during exercise on
RV contractile reserve has not been quantified in post-PEA
patients, despite RV function being the main predictor of
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outcome and exercise capacity in PH, irrespective of any
change in PVR.8 Recently, we validated a novel cardiac
magnetic resonance (CMR) imaging technique that enables
accurate and reproducible quantification of biventricular
volumes during uninterrupted strenuous exercise and contin-
ued breathing.9 This represents the ideal tool to investigate
subtle RV dysfunction that may only become evident under
the hemodynamic stress of exercise.10
The aim of this study was to evaluate RV afterload and RV
function during exercise in patients with normalized resting
mPAP after PEA. We compared post-PEA patients with healthy
controls and CTEPH patients with the hypothesis that
differences in pulmonary vascular and RV function would be
more appreciable during exercise and may be associated with
exercise intolerance in post-PEA patients. Furthermore, we
sought to assess whether the relationship between PVR and
CPA remains constant during exercise in the different study
populations and whether CPA is a better predictor of exercise
capacity than PVR or right ventricular ejection fraction (RVEF).
Finally, we evaluated the effects of a single oral dose of the
pulmonary vasodilator sildenafil on exercise hemodynamics
and RV function in the post-PEA patients.
Methods
Subjects
Fourteen healthy subjects volunteered to participate after
responding to local advertisements. All subjects were (1)
healthy; (2) had no history of cardiovascular disease, symp-
toms, or risk factors; and (3) had a normal ECG and
transthoracic echocardiogram. Given the constraints of
recruiting healthy subjects for an invasive study protocol,
we did not attempt to match age and gender in control
subjects with the CTEPH and post-PEA patients. However,
where appropriate, we included an analysis of the 7 oldest
controls and 7 youngest CTEPH patients such that age and
gender in the 3 comparison groups were similar.
The CTEPH group consisted of 15 consecutive patients
with documented CTEPH who were referred to our institution
for further investigation regarding suitability for PEA. Diagno-
sis of CTEPH was established in all patients by ventilation/
perfusion scan, pulmonary angiography, and right heart
catheterization in accordance with contemporary guide-
lines.11 None of the patients were on medical therapy with
a pulmonary vasodilator.
The group of post-PEA patients consisted of 7 patients in
whom mPAP normalized (≤25 mm Hg) measured at
least 6 months after PEA. Six of the post-PEA patients were
also included in the CTEPH group prior to surgery. Patients
with resting mPAP >25 mm Hg or pulmonary capillary wedge
pressure (PCWP) >15 mm Hg after surgery were excluded.
The study protocol conformed to the Declaration of
Helsinki and was approved by the local ethics committee.
All patients provided informed consent.
Study Design
First, cardiopulmonary exercise testing was performed on an
upright cycle ergometer (ER900 and Oxycon Alpha, Jaeger,
Germany) using a continuous ramp protocol until exhaustion.
Breath-by-breath analysis provided measures of oxygen
consumption at peak exercise (VO2 peak), maximal power
output in watts (Pmax), and the minute ventilation–carbon
dioxide production relationship (VE/VCO2 slope).
Twenty-four hours later, all subjects underwent exercise
CMR with simultaneous invasive pressure measurement. Prior
to exercise, a 7-Fr pulmonary artery catheter was inserted in
the internal jugular vein and guided under fluoroscopy or
pressure curve monitoring to the proximal right main pulmo-
nary artery. A 20-gauge arterial catheter was placed in the
radial artery. In the CMR suite, these catheters were attached
to CMR-compatible pressure transducers that were connected
to a PowerLab recording system (AD Instruments, Oxford,
United Kingdom).
Patients underwent exercise CMR at rest and at 25%, 50%,
and 66% of maximal power output in watts determined during
the previous cardiopulmonary exercise testing. We have
previously demonstrated that 66% of the maximal upright
exercise power (in watts) corresponded to the maximal
sustainable exercise intensity in a supine position.9 Thus,
these workloads will subsequently be referred to as rest, low-,
moderate-, and peak-intensity exercise. During the exercise
CMR protocol, pulmonary and systemic arterial pressures were
continuously recorded by the pulmonary and radial artery
catheters and analyzed off-line using LabChart v6.1.1 (AD
Instruments). All pressure measurements were averaged over
10 consecutive cardiac cycles during unrestricted respira-
tion.12 In the post-PEA patients, exercise CMR was repeated
30 to 60 minutes after administration of a single oral dose of
sildenafil. The same absolute workload was used during both
the baseline and postsildenafil exercise evaluation.
CMR Equipment, Image Acquisition, and Analysis
Biventricular volumes were measured during supine cycling
exercise using a real-time CMR method that we previously
described in detail and have validated against invasive
standards.9 In brief, subjects performed supine exercise
within the CMR bore using a cycle ergometer with adjustable
electronic resistance (Lode, Groningen, The Netherlands).
Images were acquired with a Philips Achieva 1.5 T CMR with a
5-element phased-array coil (Philips Medical Systems, Best,
The Netherlands).
DOI: 10.1161/JAHA.114.001602 Journal of the American Heart Association 2
Pulmonary Vascular and RV Reserve After PEA Claessen et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 at KU Leuven University Library on March 24, 2015http://jaha.ahajournals.org/Downloaded from 
Using an in-house-developed software program (RightVol,
Leuven, Belgium), LV and RV endocardial contours were
manually traced on a stack of short-axis image slices with
simultaneous reference to the horizontal long-axis plane, thus
enabling the analyzers (G.C. and A.L.G.) to confirm the
position of the atrioventricular plane. End-diastolic and end-
systolic volumes (EDV and ESV) were calculated by a
summation of disks. Stroke volume (SV) was measured as
the difference between EDV and ESV. Cardiac output (CO)
was measured as the product of SV and heart rate, while
ejection fraction (EF) was calculated as SV/EDV. Total
pulmonary resistance (tPVR) was defined as the ratio of
mPAP to CO and total systemic vascular resistance as the
ratio of mean systemic arterial pressure to CO. CPA was
calculated as the ratio of RVSV to pulmonary arterial pulse
pressure. The time constant of the pulmonary circulation (RC
time) was calculated as the product of tPVR (in
mm HgsmL1) and CPA.
Statistics
Data were analyzed using IBM SPSS statistics 22 software.
Descriptive data for continuous variables are presented
as meansSD or as medians (25% and 75% percentile)
when appropriate. Comparisons between groups were
performed using 1way ANOVA and Bonferroni post-hoc
test for multiple comparisons. The effects of sildenafil
in the post-PEA group were assessed using a paired-
samples t test. The biventricular volume response from rest
to peak-intensity exercise was evaluated using a repeated-
measures ANOVA with exercise intensity as within-subject
effect and group (post-PEA patients versus controls versus
CTEPH) as a between-subject effect. Individual mPAP-flow
slope coefficients were derived from serial measurements
of mPAP and CO during incremental exercise using linear
regression analysis.12 Differences in mPAP/CO slope coef-
ficients between groups were compared using 1-way
ANOVA.
Pearson correlation coefficients were used to assess
the univariate relationships between CPA and VO2 peak. To
demonstrate the relationship between tPVR and CPA, a
nonlinear curve was fitted according to the formula y=cte/x
(hyperbola formula). The impact of exercise on the tPVR–CPA
relation was evaluated by a linear mixed model that included
tPVR, condition (rest versus exercise), and their interaction as
fixed effects. To account for the repeated nature of the data,
an unstructured variance–covariance matrix was included
in the model. Both CPA and tPVR were log-transformed to
obtain a linear association between the 2. To increase the
certainty of correct assumptions given the number of tests
performed in our experiments, a P-value <0.01 was consid-
ered significant.
Results
Clinical Characteristics
The clinical characteristics and cardiopulmonary exercise
testing data are depicted in Table 1. CTEPH and post-PEA
patients were older than the controls, whereas gender
proportions were similar. Some of the CTEPH and post-PEA
patients were receiving negative chronotropic medications
that were withheld for 24 hours prior to testing. Nevertheless,
peak heart rate was significantly lower in post-PEA and CTEPH
patients compared to controls. Post-PEA patients were in
lower New York Heart Association functional class than
CTEPH patients, although their VO2 peak was similar.
Central Hemodynamics and Biventricular
Function
As demonstrated in Table 2, resting tPVRwas lower in post-PEA
patients than in CTEPH patients (P<0.0001) and tended to be
higher than in controls (P=0.059). Resting CPA was higher in
controls than in post-PEA and CTEPH patients (P<0.0001) and
correlated strongly with VO2 peak (Figure 1A). Resting RVESV
was larger, and RVEF lower in CTEPH patients relative to both
controls and post-PEA patients (P<0.0001), the latter 2 groups
having similar values. LVEDV and LVESV were smaller in CTEPH
and post-PEA patients than in controls, whereas LVEF was
similar in all groups.
As illustrated in Figure 2A, the slope of mPAP/CO plots was
steeper in post-PEA patients relative to controls, but similar to
CTEPH patients (4.7 [4.2–10.3] versus 1.0 [0.8–1.7] versus 6.7
[5.2–10.1] mm Hg/L per minute, respectively; P<0.0001).
From rest to peak exercise, tPVR did not change significantly in
healthy controls (P=0.064) and CTEPH patients (P=0.960),
whereas it tended to increase in post-PEA patients (P=0.018;
Figure 2B). In contrast, CPA decreased in all subjects during
exercise. The absolute exercise-induced reduction in CPA
correlated highly with VO2 peak (Figure 1B). Overall, the
exercise reduction in CPA was greatest in controls (Figure 4A).
However, peak exercise CPA in control subjects still remained
higher than the resting values in CTEPH and post-PEA patients
(P<0.01). These significant differences in CPA and mPAP/CO
slope were preserved when the oldest control subjects were
considered for an age-matched comparison (Table 3).
From rest to peak exercise, RVESV decreased in controls
and increased in CTEPH and post-PEA patients (P<0.0001 for
interaction between within-subject changes during exercise
versus between-subject groups; Figure 2C). Similarly, RVEDV
decreased in controls, whereas it increased in CTEPH and
post-PEA patients (P<0.0001 for interaction). Therefore,
contrary to resting measures, peak exercise RVEF was
reduced both in CTEPH and in post-PEA patients relative to
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controls (both P<0.0001; Figure 2D). The changes in RVEF at
rest and at near-maximal intensity exercise for all individual
subjects are plotted in Figure 3. Between the patient groups,
post-PEA patients had higher RVEF and smaller RVESV
throughout exercise, respectively, than CTEPH patients
(Table 2).
At rest, the RC time (product of tPVR and CPA) was lower in
patients with CTEPH than in healthy controls (P=0.005;
Figure 4B). At peak exercise, the RC time was similar between
the different groups. Figure 5A depicts the inverse relation-
ship between tPVR and CPA, both at rest and peak exercise. At
peak exercise, the tPVR–CPA relation is shifted downward and
to the left. Figure 5B shows a plot of log(tPVR) against log
(CPA) for all groups. The lines show the best fits for rest (green
line) and peak exercise (red line). Linear mixed-model analysis
showed a significant difference in the slopes of the lines
(P=0.002). Thus, for each given value of tPVR, CPA was lower
during peak exercise than at rest and the difference was most
profound in those subjects with the lowest tPVR and highest
CPA at rest (ie, healthy subjects).
Acute Effect of Sildenafil on Exercise
Hemodynamics and RV Function in Post-PEA
Patients
The administration of sildenafil did not affect hemodynamics
or RV function in the post-PEA patients when measured at
rest (Table 4). In contrast, exercise measures improved
significantly following sildenafil. Sildenafil decreased the
mPAP/CO slope and peak exercise tPVR (Figure 6), whereas
peak exercise CPA increased (P=0.010). This was associated
with a reduction in RVESV and an increase in RVEF at peak
Table 1. Clinical Characteristics
Healthy Controls (n=14) CTEPH (n=15) Post-PEA (n=7) P Value
Clinical
Age, y 3615 6213* 6212* <0.0001
BSA, m2 1.880.21 1.940.28 1.990.14 0.553
BMI, kg/m2 24.25.2 28.25.4 29.85.6 0.048
Sex, M (F) 11 (3) 10 (5) 6 (1) 0.583
NYHA class
I – 1 3 0.040
II – 4 3 0.448
III – 10 1 0.022
IV – 0 0
Medications
Pulmonary vasodilators 0 0 0
Negative chronotropic drugs 5 4 0.290
b-Blockers – 4 2 0.926
Amiodarone – 1 2 0.163
Digoxin – 1 1 0.563
Biochemical
NTproBNP, ng/L 28 (5–41) 399 (232–1271)* 118 (66–343) <0.0001
CPET
VO2 peak, mLkg1min1 34.48.0 13.03.3* 15.04.3* <0.0001
VO2 peak, % of predicted 9424 5517* 6315* <0.0001
Peak HR, bpm 17418 12619* 11423* <0.0001
Peak power, W 21567 7729* 9137* <0.0001
VE/VCO2 0.0260.005 0.0430.006* 0.0350.005 <0.0001
BMI indicates body mass index; BSA, body surface area; CPET, cardiopulmonary exercise testing; CTEPH, chronic thromboembolic pulmonary hypertension; F, female; HR, heart rate; M,
male; NTproBNP, N-terminal pro-brain natriuretic peptide; NYHA, New York Heart Association; post-PEA, patients after pulmonary endarterectomy; VE/VCO2, minute ventilation-carbon
dioxide production relationship; VO2, oxygen consumption; W, watts.
*P<0.01 vs healthy controls.
Data presented as meanSD or median (25% and 75% percentile).
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Table 2. Biventricular Function and Hemodynamics During Exercise CMR With Simultaneous Invasive Pressure Measurement
Controls (n=14) CTEPH (n=15) Post-PEA (n=7) P Value
HR, bpm
Rest 667 7812 8214 0.004
Peak ex 14911 12020* 10826* <0.0001
mPAP, mm Hg
Rest 103 4410* 215*† <0.0001
Peak ex 228 6511* 384*† <0.0001
PA pulse pressure, mm Hg
Rest 103 5211* 256*† <0.0001
Peak ex 2411 7816* 4810*† <0.0001
PCWP, mm Hg
Rest – 103 92 0.902
Peak ex – – – –
mSAP, mm Hg
Rest 9314 9313 8417 0.351
Peak ex 11415 11522 9713 0.302
LVEDV, mL
Rest 16244 11227* 11718 0.001
Peak ex 15643 10226* 12920 0.001
RVEDV, mL
Rest 16147 17746 12818 0.059
Peak ex 14843 20043* 15726 0.005
LVESV, mL
Rest 6824 4416* 4213 0.003
Peak ex 4814 3615 4611 0.083
RVESV, mL
Rest 6926 11437* 5612† <0.0001
Peak ex 4215 13235* 7015† <0.0001
LVSV, mL
Rest 9424 6817* 758 0.002
Peak ex 10832 6621* 8312 <0.0001
RVSV, mL
Rest 9224 6315* 738 <0.0001
Peak ex 10730 6820* 8714 0.001
LVEF, %
Rest 58.85.7 61.39.1 64.56.2 0.258
Peak ex 69.24.4 64.512.5 64.84.6 0.316
RVEF, %
Rest 58.35.5 36.26.4* 57.04.5† <0.0001
Peak ex 72.25.0 34.08.2* 55.94.2*† <0.0001
CO, L/min
Rest 6.21.9 5.11.6 6.11.4 0.200
Peak ex 16.25.3 7.90.7* 9.53.8* <0.0001
Continued
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Table 2. Continued
Controls (n=14) CTEPH (n=15) Post-PEA (n=7) P Value
CI, L/min per m2
Rest 3.30.8 2.60.6 3.10.7 0.059
Peak ex 8.52.3 4.01.0* 4.71.7* <0.0001
PVR, dynesscm5
Rest – 584182 16067† <0.0001
Peak ex – – – –
tPVR, dynesscm5
Rest 13449 728191* 287105† <0.0001
Peak ex 11449 724258* 364124† <0.0001
tPVR, wood units
Rest 1.70.6 9.12.4* 3.61.2† <0.0001
Peak ex 1.40.6 9.13.2* 4.61.6† <0.0001
tSVR, dynesscm5
Rest 1310477 1580558 1160374 0.148
Peak ex 617200 1274472* 922409 0.001
CPA, mL/mm Hg
Rest 9.73.1 1.30.4* 3.10.6* <0.0001
Peak ex 5.11.8 0.90.3* 1.90.3* <0.0001
RC time, s
Rest 0.890.25 0.650.11* 0.640.22 0.002
Peak ex 0.410.17 0.440.10 0.510.22 0.358
CI indicates cardiac index; CMR, cardiac magnetic resonance; CO, cardiac output; CPA, pulmonary arterial compliance; CTEPH, chronic thromboembolic pulmonary hypertension; EDV, end-
diastolic volume; EF, ejection fraction; ESV, end-systolic volume; ex, exercise; HR, heart rate; LV, left ventricle; mPAP, mean pulmonary arterial pressure; mSAP, mean systemic arterial
pressure; PA, pulmonary arterial; PCWP, pulmonary capillary wedge pressure; post-PEA, patients after pulmonary endarterectomy; PVR, pulmonary vascular resistance; RC, time constant;
RV, right ventricle; SV, stroke volume; tPVR, total pulmonary vascular resistance; tSVR, total systemic vascular resistance.
*P<0.01 vs healthy controls.
†P<0.01 vs CTEPH.
A B
Figure 1. Correlation between (A) peak oxygen consumption (VO2 peak) and pulmonary arterial
compliance (CPA) at rest and (B) between VO2 peak and the change in CPA from rest to peak exercise (ΔCPA).
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exercise (P<0.01), whereas peak exercise LVESV and LVEF
were unchanged. The RC time remained constant before and
after sildenafil (Figure 7).
Discussion
The present study documents significant exercise intolerance
in post-PEA subjects despite a decrease of mPAP to near-
normal values and normal RVEF at rest. Using novel exercise
CMR combined with invasive PAP measures, this reduction in
exercise capacity can be explained by (1) increased RV
afterload during exercise, and (2) significant chronotropic
impairment. Despite increased resistive and pulsatile RV
afterload, post-PEA patients have an increase in SV from rest
to peak exercise, in contrast to CTEPH. However, SV
augmentation during exercise in post-PEA patients is associ-
ated with an increase in RV volumes as opposed to the
observed reduction in healthy subjects. These hemodynamic
abnormalities during exercise were partially reversible after
administration of a single oral dose of sildenafil. Thus,
exercise measures provide critical insights into the patho-
physiological mechanisms underpinning exercise intolerance
in post-PEA patients and raise clinical questions as to whether
there may be a role for pulmonary vasodilators in further
improving pulmonary vascular physiology and functional
capacity.
B
C D 
A
Figure 2. Pulmonary vascular and right ventricular reserve in healthy subjects, patients with chronic
thromboembolic pulmonary hypertension (CTEPH), and patients after pulmonary endarterectomy (post-
PEA). A, Relationship between mean pulmonary artery pressure (mPAP) and cardiac output during
incremental exercise. Changes in (B) total pulmonary vascular resistance (tPVR), (C) right ventricular end-
systolic volume (RVESV), and (D) RV ejection fraction (RVEF) from rest to peak exercise. At each exercise
intensity, *P<0.01 for difference between healthy controls and CTEPH patients, †P<0.01 for difference
between healthy controls and post-PEA patients, and ‡P<0.01 for difference between CTEPH and post-PEA
patients.
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Table 3. Comparison of Biventricular Function and Hemodynamics Between Age-Matched Controls, CTEPH, and Post-PEA Patients
Controls (n=7) CTEPH (n=7) Post-PEA (n=7) P Value
Age, y 4811 5816 6212 0.14
HR, bpm
Rest 646 8017 8214 0.030
Peak ex 14812 11223 10826* 0.004
mPAP, mm Hg
Rest 113 4511* 215† <0.0001
Peak ex 258 6113* 384† <0.0001
PA pulse pressure, mm Hg
Rest 123 5212* 256† <0.0001
Peak ex 3010 7616* 4810† <0.0001
mSAP, mm Hg
Rest 10312 9015 8417 0.068
Peak ex 12311 10820 9713 0.265
LVEDV, mL
Rest 16241 12030 11718 0.024
Peak ex 15337 11128 12920 0.046
RVEDV, mL
Rest 16047 19248 12818 0.027
Peak ex 14536 21142* 15726 0.006
LVESV, mL
Rest 6420 4717 4213 0.056
Peak ex 4412 3714 4611 0.429
RVESV, mL
Rest 6523 12445* 5612† 0.001
Peak ex 3713 13843* 7015† <0.0001
LVSV, mL
Rest 9825 7414 758 0.026
Peak ex 11027 7418 8312 0.010
RVSV, mL
Rest 9426 6812 738 0.020
Peak ex 10826 7316 8714 0.011
LVEF, %
Rest 60.85.7 62.05.5 64.56.2 0.487
Peak ex 71.63.5 67.16.5 64.84.6 0.060
RVEF, %
Rest 59.76.2 36.68.2* 57.04.5† <0.0001
Peak ex 75.04.8 35.79.8* 55.94.2*† <0.0001
CO, L/min
Rest 6.21.8 5.71.7 6.11.4 0.840
Peak ex 16.45.0 8.32.7* 9.53.8 0.002
Continued
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Table 3. Continued
Controls (n=7) CTEPH (n=7) Post-PEA (n=7) P Value
CI, L/min per m2
Rest 3.20.8 2.80.8 3.10.7 0.624
Peak ex 8.52.4 4.11.3* 4.71.7* 0.001
tPVR, dynesscm5
Rest 15757 669230* 287105† <0.0001
Peak ex 12757 651289* 364124† <0.0001
tPVR, wood units
Rest 2.00.7 8.42.9* 3.61.2† <0.0001
Peak ex 1.60.7 8.13.6* 4.61.6† <0.0001
tSVR, dynesscm5
Rest 1475572 1327284 1160374 0.405
Peak ex 660228 1109283 922409 0.102
CPA, mL/mm Hg
Rest 8.53.6 1.40.4* 3.10.6* <0.0001
Peak ex 3.90.9 1.00.3* 1.90.3* <0.0001
RC time, s
Rest 0.880.18 0.640.14 0.640.22 0.031
Peak ex 0.370.20 0.450.12 0.510.22 0.358
CI indicates cardiac index; CO, cardiac output; CPA, pulmonary arterial compliance; CTEPH, chronic thromboembolic pulmonary hypertension; EDV, end-diastolic volume; EF, ejection
fraction; ESV, end-systolic volume; ex, exercise; HR, heart rate; LV, left ventricle; mPAP, mean pulmonary arterial pressure; mSAP, mean systemic arterial pressure; PA, pulmonary arterial;
post-PEA, patients after pulmonary endarterectomy; RC, time constant; RV, right ventricle; SV, stroke volume; tPVR, total pulmonary vascular resistance; tSVR, total systemic vascular
resistance.
*P<0.01 vs healthy controls.
†P<0.01 vs CTEPH.
A B
Figure 3. Individual changes in right ventricular end-systolic volume (RVESV) and ejection fraction (RVEF)
from rest to peak exercise. A, RVESV decreases from rest to peak exercise in all healthy subjects (green
lines and symbols), whereas an increase is seen in post-PEA patients (blue lines) and CTEPH patients (red
lines). B, All healthy subjects demonstrate an increase in RVEF during exercise as opposed to CTEPH and
post-PEA patients. CTEPH indicates chronic thromboembolic pulmonary hypertension; post-PEA, patients
after pulmonary endarterectomy.
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Exercise Evaluation Facilitates Recognition of
Subtle Pulmonary Vascular Disease
For patients with CTEPH, PEA is the “gold standard”
procedure and currently the only potentially “curative”
treatment option.13 After successful PEA, most patients
have a sustained improvement of functional status, hemo-
dynamics, RV function,3 and overall survival.4 Nevertheless,
despite a normalization of mPAP and/or PVR, exercise
capacity does not return to normal in a significant
BA
Figure 4. Effect of exercise on pulmonary arterial compliance (CPA). A, CPA decreases in all groups with
increasing cardiac output. Although CPA decreases during exercise even in healthy subjects, CPA is
significantly lower at rest and throughout exercise in patients with chronic thromboembolic pulmonary
hypertension (CTEPH) and patients after pulmonary endarterectomy (post-PEA). B, Mean resistance-
compliance product (RC time) for each subgroup relative to cardiac output. The RC time is lower at rest in
CTEPH patients and post-PEA patients relative to healthy subjects and decreases in all groups during
exercise. At each exercise intensity, *P<0.01 for difference between healthy controls and CTEPH and
†P<0.01 for difference between healthy controls and post-PEA patients.
A B
Figure 5. Effect of exercise on the pulmonary vascular resistance-compliance relationship (tPVR–CPA). A,
tPVR–CPA for each subject is plotted at rest and at peak exercise (66% ofmaximal power during cardiopulmonary
exercise testing). B, Plot of log(tPVR) against log(CPA) for healthy subjects, patients with chronic thromboembolic
pulmonary hypertension (CTEPH), and patients after pulmonary endarterectomy (post-PEA). Best-fit lines are
shown for rest (green line,R2=0.91) and peak exercise (red line,R2=0.85). Linearmixed-model analysis showeda
significant difference in the slopes of the lines as depicted by the arrow (*P=0.002).
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Table 4. Comparison of Biventricular Function and Hemodynamics Before and After Sildenafil in Post-PEA Patients
Post-PEA (n=7)
P ValueBaseline Sildenafil
HR, bpm
Rest 8214 869 0.759
Peak ex 10826 11223 0.929
mPAP, mm Hg
Rest 215 184 0.117
Peak ex 384 302 <0.0001
PA pulse pressure, mm Hg
Rest 256 215 0.035
Peak ex 4810 4210 <0.0001
mSAP, mm Hg
Rest 8417 868 0.383
Peak ex 9713 1059 0.010
LVEDV, mL
Rest 11718 11317 0.671
Peak ex 12920 13022 0.804
RVEDV, mL
Rest 12818 13023 0.301
Peak ex 15726 14629 0.051
LVESV, mL
Rest 4213 3910 0.913
Peak ex 4611 4011 0.177
RVESV, mL
Rest 5612 5714 0.055
Peak ex 7015 5612 0.007
LVSV, mL
Rest 758 7411 0.784
Peak ex 8312 9013 0.153
RVSV, mL
Rest 738 7314 0.617
Peak ex 8714 9018 0.390
LVEF, %
Rest 64.56.2 65.76.0 0.971
Peak ex 64.84.6 69.94.2 0.099
RVEF, %
Rest 57.04.5 56.45.8 0.577
Peak ex 55.94.2 61.91.2 0.007
CO, L/min
Rest 6.11.4 6.41.6 0.500
Peak ex 9.50.9 10.33.5 0.391
Continued
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proportion of patients after PEA.5,6 This may be explained
by a degree of residual thrombi in subsegmental pulmonary
arteries and/or distal arteriopathy, thereby decreasing
pulmonary vascular reserve although resting PVR is in
the normal range. In these patients, the detection of
abnormal pulmonary vascular reserve during exercise is
important as it provides pathophysiological insights into the
mechanisms limiting exercise capacity after PEA.7 It also
provides measures that can be used to assess whether
early surgical and pharmacological interventions may
improve exercise hemodynamics, functional capacity, and
prognosis.
Despite the rationale for exercise evaluation, the defini-
tion of a clear-cut threshold for a normal pulmonary
vascular response to exercise has been a source of debate,
given that healthy individuals frequently exceed the pro-
posed cut-off value of mPAP=30 mm Hg during exercise,
especially trained athletes and those aged >50 years.14–16
Indeed, due to the near linear relationship between mPAP
and CO, highly trained athletes can attain considerably
higher mPAP at peak exercise compared to nonathletes, as
they are able to achieve higher COs.15,16 Thus, pulmonary
artery pressures should be considered relative to workload
and/or CO. Currently, based on multiple invasive and
noninvasive studies, it has been suggested that a mPAP/
CO slope of >3 mm Hg/L per minute represents an
abnormal pulmonary vascular response to exercise.12
Accordingly, the pulmonary vascular response of the post-
PEA patients in our study can be considered abnormal,
despite their resting mPAP and PVR being below the
threshold of persistent postoperative PH.17
A second mechanism that contributed substantially to
the impaired CO augmentation and exercise intolerance in
the post-PEA patients was an attenuated heart rate
response. The observed chronotropic incompetence may
have been compounded by the recent use of negative
chronotropic medications in some patients but may also
reflect the disease process. In patients with pulmonary
arterial hypertension, chronotropic incompetence has
been associated with RV myocardial b-adrenoreceptor
downregulation in proportion to the physiologic severity of
disease.18,19 However, the degree of chronotropic incom-
petence did not improve following PEA despite a clear
reduction of resting pulmonary vascular hemodynamics. It is
possible that the remaining chronotropic impairment in
post-PEA patients reflects the persisting RV pressure
overload and functional impairment during exercise. Another
putative mechanism may be that chronic right atrial stretch
due to longstanding RV pressure overload prior to PEA-
induced electrical and structural remodeling of the right
atrium and sinus node,20,21 which might not be fully
reversible after PEA.
Table 4. Continued
Post-PEA (n=7)
P ValueBaseline Sildenafil
CI, L/min per m2
Rest 3.10.7 3.10.8 0.529
Peak ex 4.71.7 5.11.6 0.398
tPVR, dynesscm5
Rest 287105 24790 0.086
Peak ex 364124 25284 0.003
tSVR, dynesscm5
Rest 1160374 1166383 0.270
Peak ex 922409 887295 0.024
CPA, mL/mm Hg
Rest 3.10.6 3.61.2 0.128
Peak ex 1.90.3 2.20.5 0.010
RC time, s
Rest 0.640.22 0.630.21 0.700
Peak ex 0.510.22 0.410.14 0.039
CI indicates cardiac index; CO, cardiac output; CPA, pulmonary arterial compliance; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; ex, exercise; HR, heart rate;
LV, left ventricle; mPAP, mean pulmonary arterial pressure; mSAP, mean systemic arterial pressure; PA, pulmonary arterial; post-PEA, patients after pulmonary endarterectomy; RC, time
constant; RV, right ventricle; SV, stroke volume; tPVR, total pulmonary vascular resistance; tSVR, total systemic vascular resistance.
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Response of the Right Ventricle to Increased
Afterload During Exercise
In this study, we also evaluated the impact of an abnormal
exercise-induced increase in RV afterload on RV performance
itself. This is important because RV function is the primary
determinant of exercise capacity and outcome in PH,
irrespective of changes in PVR.8 When evaluated at rest,
CO and RV performance were indistinguishable between
post-PEA patients and controls, indicating that RV contrac-
tility was sufficiently preserved to maintain optimal coupling
between the RV and the pulmonary circulation at rest.
Imaging during exercise enables quantification of RV con-
tractile reserve as the change in RVEF or SV from rest to
maximal exercise.22
We observed that the post-PEA patients had a similar
increase in SV from rest to peak exercise compared to healthy
subjects, suggesting that RV contractile reserve was pre-
served. However, the mechanisms by which the RV generated
the increased SV during exercise were significantly different
between post-PEA patients and healthy subjects. In healthy
subjects, SV augmentation is mainly achieved by a decrease
in ESV, reflecting contractile reserve, whereas EDV remains
relatively unchanged or decreases slightly at near-maximal
exercise due to reduced filling times.9 In contrast, the
exercise-induced increase in SV in the post-PEA patients
was achieved by concomitant increases in RV EDV and ESV.
Thus, RVEF did not increase during exercise (Figures 2 and 3).
This suggests that, although global RV performance is
preserved, the RV becomes more dependent upon
A B
C D
Figure 6. Sildenafil increases pulmonary vascular and right ventricular reserve in patients after pulmonary
endarterectomy (post-PEA). A, Relationship between mean pulmonary artery pressure (mPAP) and cardiac
output (CO) before and after sildenafil. Changes in (B) total pulmonary vascular resistance (tPVR), (C) right
ventricular end-systolic volume (RVESV), and (D) RV ejection fraction (RVEF) from rest to peak exercise.
Values are shown for the interaction between sildenafil administration and exercise intensity as within-
subjects effects. At each exercise intensity, *P<0.01 for the difference between baseline and sildenafil.
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Frank–Starling recoil to meet its output requirements in post-
PEA patients. A recent study in patients with long-term
pulmonary arterial hypertension and a clinically stable profile
demonstrated that preserved CO may mask RV failure
progression, and that changes in RV volumes may be sensitive
parameters to predict ultimate deterioration, even at the time
of clinical stability.23 Therefore, evaluation of RV volumes and
RVEF during exercise may be clinically important to detect
early RV failure development.
Pulmonary Arterial Compliance Decreases During
Exercise
Resistance does not adequately describe afterload when
considering the pulsatile nature of the circulation. CPA
represents the ability of the pulmonary circulation to stretch
in response to an applied pressure, and its inverse relation-
ship with PVR means that small increases in PVR are
associated with large decreases in CPA, thereby making it
an important marker of early pulmonary vascular disease.24,25
Previous studies have demonstrated that the product of CPA
and PVR remains constant over time and suggested that a
pathologic hemodynamic response to exercise is character-
ized by an increase in PVR together with a decrease in CPA.
7,24
However, Tedford et al showed that the coupling between CPA
and PVR can change during exercise in patients with left-sided
heart disease because of an increase in PCWP.26 More
recently, MacKenzie Ross et al showed that it is not only an
increase in PCWP that can change the product of PVR and
CPA, but also that proximal CTEPH and PEA surgery are able to
alter this relationship.27
In this study, we extend these findings by demonstrating
that in healthy subjects, both tPVR and CPA decrease during
exercise. Therefore, the product of tPVR and CPA does not
remain fixed from rest to exercise in healthy subjects, but CPA
becomes lower for any given value of tPVR (Figures 4 and 5).
The reduction of CPA during exercise can be explained by
passive distention of the pulmonary vascular vessels with
increasing CO such that the vessels become stiffer (less
compliant) as their diameter increases.28 Exercise-associated
sympathetic nervous system stimulation may be another
mechanism to explain the decrease in CPA during exercise in
healthy subjects.29,30 Indeed, it has been shown in normal
dogs that sympathetic nervous system activation may
increase characteristic impedance without significantly chang-
ing PVR.30
Intriguingly, the reduction in RC time during exercise was
most profound in the control subjects, indicating that the
relative increase in pulsatile load during exercise is greater in
healthy individuals than in CTEPH and post-PEA patients.
However, the greater reduction in RC time is a simple
consequence of the fact that the compliance and resistance
of the pulmonary vasculature were far better in healthy
subjects at baseline. As explained above, at maximal exercise
there is a convergence whereby the pulmonary circulation
became “stiff”. In healthy subjects this occurred at very high
COs when the vascular resistance was low, whereas in the
CTEPH patients this point was reached with only very modest
increase in CO and no reduction in PVR. Another mechanism
that may have contributed to the proportionately greater
reduction in CPA in healthy controls may be the higher
exercise-induced increase in heart rate. It has been shown for
A B
Figure 7. Effect of sildenafil on pulmonary arterial compliance (CPA) and mean resistance–compliance
product (RC time) in patients after pulmonary endarterectomy. Changes in (A) CPA and (B) RC time from rest
to peak exercise before and after sildenafil. At each exercise intensity, *P=0.01 for the difference between
baseline and sildenafil.
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both the systemic and the pulmonary circulation that an
increase in heart rate is associated with a reduction in arterial
compliance.31,32 Thus, the change in CPA during exercise per
se cannot be used to distinguish between a normal and
abnormal pulmonary vascular reserve. Nevertheless, whereas
controls demonstrated the greatest reductions in CPA during
exercise, peak exercise values still remained higher than the
resting values in CTEPH and post-PEA patients. Moreover,
despite the relatively greater contribution of pulsatile load, the
total RV load remained much lower in the healthy subjects as
reflected by the lower peak exercise mPAP and tPVR.
Effects of Sildenafil on Exercise Hemodynamics
in Post-PEA Patients
Our study extends current understanding of the pathophys-
iology of exercise intolerance in post-PEA patients with
potential therapeutic implications. Skoro-Sajer et al demon-
strated that up to 77.7% of CTEPH patients have some degree
of pulmonary vascular reactivity during nitric oxide adminis-
tration prior to PEA, indicating distal vasoconstriction, and
that a decrease in mPAP >10% predicts immediate postop-
erative PVR decrease and better long-term outcome after
PEA.33 Our current results indicate that even after successful
PEA some residual pulmonary vasoconstriction remains
present, which can be partially reversed after administration
of a pulmonary vasodilator. Importantly, the beneficial effects
of sildenafil were measurable during exercise, but not at rest.
It is yet to be determined whether the short-term improve-
ments in exercise hemodynamics and RV function following
sildenafil administration translate to improved clinical out-
comes with long-term pulmonary vasodilators. Our study
provides a rationale for investigating the efficacy of post-PEA
pulmonary vasodilator therapy and suggests that exercise
metrics should be included in the outcome measures.
Limitations
This is the largest series to include invasive pulmonary artery
measures in CTEPH patients and healthy controls. Recruiting
healthy controls for such a study is challenging and is seldom
attempted. In this context, we felt that the very small but
potentially serious potential for adverse events in performing
PCWP measurements during exercise was unacceptable, so
PCWP was only measured at rest in the CTEPH and post-PEA
patients and no PCWP measurements were obtained in
controls. Therefore, we could not assess the degree to which
PCWP influenced the changes in CPA and PVR observed during
exercise. Although PCWP can increase to as high as
30 mm Hg in exercising athletes,34 increases in PCWP only
become significant at very high COs,35 whereas we observed
a reduction in CPA even during low-intensity exercise.
Secondly, given the constraints of recruiting healthy
subjects for an invasive study protocol and the low
community prevalence of CTEPH, we did not attempt to
match the control, CTEPH, and post-PEA cohorts for age.
Nevertheless, the RV pressure–volume response to exercise
remained significantly different between control subjects
and post-PEA patients when only the oldest controls,
matched for age, were considered in a subanalysis
(Table 3). Also, the small sample size may have increased
the probability of type II statistical errors due to lack of
power, whereas the use of multiple comparisons increased
the chances of type I errors. We have addressed the latter
concern by increasing the significance level required for
rejecting the null hypothesis to P<0.01. The established
accuracy of exercise CMR measures enabled us to evaluate
meaningful hemodynamic differences within this modest-
sized cohort with high levels of statistical significance.
Lastly, the use of a fluid-filled catheter to calculate pulse
pressure can be problematic due to catheter ringing,
particularly in healthy subjects where small changes in
pulse pressure can lead to significant differences in
compliance.36 High-fidelity micromanometer-tipped cathe-
ters would have provided more precise pressure measures
but are unable to be used in the CMR environment.
Conclusions
Despite normalized hemodynamics at rest, post-PEA patients
have significant exercise intolerance, which is explained by
abnormal pulmonary vascular reserve and chronotropic incom-
petence. The mPAP/CO slope and CPA are sensitive measures
of resistive and pulsatile pulmonary vascular function, which
correlate strongly with exercise capacity. Sildenafil partially
attenuates abnormalities in post-PEA hemodynamics, providing
rationale for studies investigating the efficacy of chronic
pulmonary vasodilator therapy in this group.
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